Development of a blocking enzyme-linked immunosorbent assay for detection of serum antibodies to O157 antigen of Escherichia coli

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 2, 1998, Pages 242-246

  Laegreid, William ^a   Hoffman, Mark ^b   Keen, James ^a   Elder, Robert ^a   Kwang, Jimmy ^a  

^a U S MEAT ANIMAL RESEARCH CENTER   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL ANTIGEN O157; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY O157; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BRUCELLA ABORTUS; CATTLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; YERSINIA ENTEROCOLITICA;

BRUCELLA ABORTUS; ESCHERICHIA COLI; YERSINIA ENTEROCOLITICA;

EID: 0031900537     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.2.242-246.1998     Document Type: Article

References (33)

1. Armstrong, G. L., J. Hollingsworth, and J. G. Morris. 1996. Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol. Rev. 18: 29-51.
2. Barrett, T. J., J. H. Green, P. M. Grlffin, A. T. Pavia, S. M. Ostroff, and I. K. Wachsmuth. 1991. Enzyme-linked immunosorbent assays for detecting anlibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr. Microbiol. 23:189-195.
3. Besser, T. E., D. D. Hancock, L. C. Pritchett, E. M. McRae, D. H. Rice, and P. I. Tarr. 1997. Duration of detection of fecal excretion at Escherichia coli O157:H7 in cattle. J. Infect. Dis. 175:726-729.
4. Bitzan, M., E. Moebius, K. Ludwig, D. E. Muller-Wiefel, J. Heeseman, and H. Karch. 1991. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic: syndrome. J. Pediatr. 119:380-385.
5. Bopp, C. A., K. U. Greene, F. P. Downes, E. G. Sowers, J. G. Wells, and I. K. Wachsmuth. 1987. Unusual verotoxin-producing Escherichia coil associated with hemorrhagic colitis. J. Clin. Microbiol. 25:1486-1489.
6. Caroff, M., D. R. Bundle, and M. B. Perry. 1984. Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O9. Eur. J. Biochem. 139:195-200.
7. Chart, H., S. M. Scotland, and B. Rowe. 1989. Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. J. Clin. Pathol. 42:973-976.
8. Chart, H., H. R. Smith, S. M. Scotland, B. Rowe, D. V. Milford, and C. M. Taylor. 1991. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 337:138-140.
9. Cheville, N. F., S. C. Olsen, A. F. Jensen, M. G. Stevens, M. V. Palmer, and A. M. Florance. 1996. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am. J. Vet. Res. 57: 1153-1156.
10. Cray, W. C., and H. W. Moon. 1995. Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl. Environ. Microbiol. 61: 1586-1590.
11. Dodds, K. L., M. B. Perry, and I. J. McDonald. 1987. Electrophoretic and immunochemical study of the lipopolysaccharides produced by chemostat-grown Escherichia coli O157. J. Gen. Microbiol. 133:2679-2687.
12. Dujardin, B., J. Van den Ende, A. Van Gompel, J. P. Unger, and P. Van der Stuyft. 1994. Likelihood ratios: a real improvement for clinical decision making? Eur. J. Epidemiol. 10:29-36.
13. Ferris, K. E., and D. A. Miller. 1996. Salmonella serotypes from animals and related sources reported during July 1995-June 1996, p. 505-526. In Proceedings of the 100th Annual Meeting of the United States Animal Health Association.
14. Garber, L. P., S. J. Wells, D. D. Hancock, M. P. Doyle, J. Tuttle, J. A. Shere, and T. Zhao. 1995. Risk factors for fecal shedding of Escherichia coli O157:H7 in dairy calves. J. Am. Vet. Med. Assoc. 207:46-49.
15. Greiner, M., D. Sohr, and P. Gobel. 1995. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J. Immunol. Methods 185:123-132.
16. Hancock, D. D., T. E. Besser, M. L. Kinsel, P. I. Tarr, D. H. Rice, and M. G. Paros. 1994. The prevalence of Escherichia coli O157:H7 in dairy and beef cattle in Washington state. Epidemiol. Infect. 113:199-207.
17. Hoffman, M., T. Casey, W. Laegreid, and B. Bosworth. Bovine immune response to Escherichia coli O157:H7. Submitted for publication.
18. Johnson, R. P., L. Boag, S. Anderson, R. Holtslander, K. Rahn, R. C. Clarke, S. A. Renwick, D. Alves, J. B. Wilson, and J. Spika. 1994. Brucella abortus serology in cattle naturally infected with Escherichia coli O157:H7. Vet. Rec. 135:382-383.
19. Johnson, R. P., W. C. Cray, and S. T. Johnson. 1996. Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7. Infect. Immun. 64:1879-1883.
20. Lelve, L., and V. K. Shovlin. 1968. Physical, chemical and immunolngical properties of lipopolysaccharide released from Escherichia coli by ethylene-diaminetetraactetate. J. Biol. Chem. 243:6384-6391.
21. Perry, M. B., and D. R. Bundle. 1990. Anligenic relationships of the lipopolysaccharides of Escherichia hermanii strains with those of Escherichia coli O157:H7, Brucella melitensis, and Brucella abortus. Infect. Immun. 58:1391-1395.
22. Perry, M. B., D. R. Bundle, L. Machean, J. A. Perry, and D. W. Griffith. 1986. The structure of the antigenic lipopolysaccharide O-chains produced by Salmonella urbana and Salmonella godesburg. Carbohydr. Res. 156:107-122.
23. Perry, M. B., L. Machean, and D. W. Griffith. 1986. Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli O157:H7. Biochem. Cell Biol. 64:21-28.
24. Reed, G. F., B. D. Meade, and M. C. Steinhoff. 1995. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 96:600-603.
25. Reymond, D., R. P. Johnson, M. A. Karmali, M. Petric, M. Winkler, S. Johnson, K. Rahn, S. Renwick, J. Wilson, R. C. Clarke, and J. Spika. 1996. Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J. Clin. Microbiol. 34:2053-2057.
26. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T, Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
27. Rosner, B. 1987. Fundamental biostatistics, p. 369-441. Duxbury Press, Boston, Mass.
28. Simel, D. L., G. P. Samsa, und D. B. Matchar. 1991. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J. Clin. Epidemiol. 44:763-770.
29. Stuart, F. A., and M. J. Corbel. 1982. Identification of a serological crossreaction between Brucella abortus and Escherichia coli O157. Vet. Rec. 110: 202-203.
30. Tarr, P. I., M. A. Neill, C. R. Clausen, J. W. Newland, R. J. Neill, and S. L. Moseley. 1989. Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987. J. Infect. Dis. 159:344-347.
31. Valenstein, P. N. 1990. Evaluating diagnostic tests with imperfect standards. Am. J. Clin. Pathol. 93:252-258.
32. Westerman, R. B., Y. He, J. E. Keen, E. T. Littledike, and J. Kwang. 1997. Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia cali O157. J. Clin. Microbiol. 35:679-684.
33. Whipp, S. C., M. A. Rusmussen, and W. C. Cray. 1994. Animals as a source of Encherichia coli pathogenic for human beings. J. Am. Vet. Med. Assoc. 204:1168-1175.